Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2025-12-25 @ 4:01 AM
NCT ID:
NCT06817902
Eligibility Criteria:
Inclusion Criteria:
* Established diagnosis of Mild cognitive impairment (MCI)/mild AD
* Evidence for central nervous system (CNS) amyloidosis (e.g., Amyloid Positron Emission Tomography (PET) or Cerebrospinal fluid (CSF) biomarkers consistent with AD)
* Prior brain imaging performed
* Mini Mental Status Examination (MMSE) \>24
* Clinical Dementia Rating (CDR) 0.5-1
* Stable dose of cholinesterase inhibitors and memantine for at least one month
* Subjects are between 40-90 years of age
Exclusion Criteria:
* Non-AD dementia including, but not limited to, Lewy body dementia, frontotemporal dementia, vascular dementia, Jakob-Creutzfeldt disease, etc.
* Inability to tolerate resting state-function magnetic resonance imaging (rs-fMRI)
* Contraindication of rs-fMRI due to implants or metal
* Seizure disorder
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
90 Years
Study:
NCT06817902
Study Brief:
Protocol Section:
NCT06817902